Biotech Valuation & Healthcare Valuation Service

By |2021-05-14T05:13:55+00:00May 10th, 2021|Categories: Business Valuation, Valtech Insights|Tags: , , , , |

Given the uncertainties associated with valuation of biotech enterprises, valuers can put stronger effort in benchmarking. A solid pool of comparable listed companies and comparable transaction will be highly useful to support valuation assumptions at different clinical trial phase.

Go to Top